These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24952901)

  • 1. Assessing the clinical utility of cancer genomic and proteomic data across tumor types.
    Yuan Y; Van Allen EM; Omberg L; Wagle N; Amin-Mansour A; Sokolov A; Byers LA; Xu Y; Hess KR; Diao L; Han L; Huang X; Lawrence MS; Weinstein JN; Stuart JM; Mills GB; Garraway LA; Margolin AA; Getz G; Liang H
    Nat Biotechnol; 2014 Jul; 32(7):644-52. PubMed ID: 24952901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the clinical utility of genomic expression data across human cancers.
    Xu X; Huang L; Chan CH; Yu T; Miao R; Liu C
    Oncotarget; 2016 Jul; 7(29):45926-45936. PubMed ID: 27322207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers.
    Xu L; Fengji L; Changning L; Liangcai Z; Yinghui L; Yu L; Shanguang C; Jianghui X
    PLoS One; 2015; 10(11):e0142433. PubMed ID: 26606135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NetNorM: Capturing cancer-relevant information in somatic exome mutation data with gene networks for cancer stratification and prognosis.
    Le Morvan M; Zinovyev A; Vert JP
    PLoS Comput Biol; 2017 Jun; 13(6):e1005573. PubMed ID: 28650955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MethCNA: a database for integrating genomic and epigenomic data in human cancer.
    Deng G; Yang J; Zhang Q; Xiao ZX; Cai H
    BMC Genomics; 2018 Feb; 19(1):138. PubMed ID: 29433427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective.
    Cooper LA; Demicco EG; Saltz JH; Powell RT; Rao A; Lazar AJ
    J Pathol; 2018 Apr; 244(5):512-524. PubMed ID: 29288495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools.
    Huang Z; Duan H; Li H
    Biomed Res Int; 2015; 2015():878546. PubMed ID: 26576432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity.
    Tan H; Bao J; Zhou X
    Sci Rep; 2015 Jul; 5():12566. PubMed ID: 26212640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
    Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
    Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
    [No Abstract]   [Full Text] [Related]  

  • 11. Epistasis in genomic and survival data of cancer patients.
    Matlak D; Szczurek E
    PLoS Comput Biol; 2017 Jul; 13(7):e1005626. PubMed ID: 28678836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic and Mitochondrial Genomic Analyses of Pediatric Brain Tumors.
    Luna B; Bhatia S; Yoo C; Felty Q; Sandberg DI; Duchowny M; Khatib Z; Miller I; Ragheb J; Prasanna J; Roy D
    Mol Neurobiol; 2015 Dec; 52(3):1341-1363. PubMed ID: 25341474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex impact of DNA methylation on transcriptional dysregulation across 22 human cancer types.
    Wang Z; Yin J; Zhou W; Bai J; Xie Y; Xu K; Zheng X; Xiao J; Zhou L; Qi X; Li Y; Li X; Xu J
    Nucleic Acids Res; 2020 Mar; 48(5):2287-2302. PubMed ID: 32002550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pan-cancer analysis of HER2 index revealed transcriptional pattern for precise selection of HER2-targeted therapy.
    Li Z; Chen S; Feng W; Luo Y; Lai H; Li Q; Xiu B; Li Y; Li Y; Huang S; Zhu X
    EBioMedicine; 2020 Dec; 62():103074. PubMed ID: 33161227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
    Liu N; Wu Y; Cheng W; Wu Y; Wang L; Zhuang L
    BMC Cancer; 2021 Apr; 21(1):460. PubMed ID: 33902514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
    Stockley TL; Oza AM; Berman HK; Leighl NB; Knox JJ; Shepherd FA; Chen EX; Krzyzanowska MK; Dhani N; Joshua AM; Tsao MS; Serra S; Clarke B; Roehrl MH; Zhang T; Sukhai MA; Califaretti N; Trinkaus M; Shaw P; van der Kwast T; Wang L; Virtanen C; Kim RH; Razak AR; Hansen AR; Yu C; Pugh TJ; Kamel-Reid S; Siu LL; Bedard PL
    Genome Med; 2016 Oct; 8(1):109. PubMed ID: 27782854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probabilistic radiographic atlas of glioblastoma phenotypes.
    Ellingson BM; Lai A; Harris RJ; Selfridge JM; Yong WH; Das K; Pope WB; Nghiemphu PL; Vinters HV; Liau LM; Mischel PS; Cloughesy TF
    AJNR Am J Neuroradiol; 2013 Mar; 34(3):533-40. PubMed ID: 22997168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients.
    Nicolasjilwan M; Hu Y; Yan C; Meerzaman D; Holder CA; Gutman D; Jain R; Colen R; Rubin DL; Zinn PO; Hwang SN; Raghavan P; Hammoud DA; Scarpace LM; Mikkelsen T; Chen J; Gevaert O; Buetow K; Freymann J; Kirby J; Flanders AE; Wintermark M;
    J Neuroradiol; 2015 Jul; 42(4):212-21. PubMed ID: 24997477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan-cancer analysis.
    Liu H; Zhang B; Sun Z
    Cancer Commun (Lond); 2020 Jan; 40(1):43-59. PubMed ID: 32067422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study.
    Moore LE; Pfeiffer RM; Poscablo C; Real FX; Kogevinas M; Silverman D; García-Closas R; Chanock S; Tardón A; Serra C; Carrato A; Dosemeci M; García-Closas M; Esteller M; Fraga M; Rothman N; Malats N
    Lancet Oncol; 2008 Apr; 9(4):359-66. PubMed ID: 18339581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.